Skip to content
Clinical Trials – home

ROHHAD syndrome Life with Disease

1 / 1 trials open to patients1 country

In short

ROHHAD syndrome is an extremely rare and life-threatening disorder that appears in otherwise healthy children, bringing dramatic weight gain, breathing problems, and disruptions to crucial body systems. With fewer than 200 documented cases worldwide, this condition remains a medical mystery, challenging families and doctors alike as they navigate an uncertain path with no known cure.

Key points

  • ROHHAD is so rare that fewer than 200 cases have been documented worldwide, yet it carries a mortality rate of 50-60%, making early recognition critical.
  • Children appear completely healthy at birth and develop normally until sudden, dramatic weight gain signals the beginning of this life-threatening syndrome.
  • The condition's name is an acronym describing its hallmark features: Rapid-onset Obesity, Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation.
  • Children lose the automatic ability to breathe properly, requiring ventilator support to survive, especially during sleep.
  • There is no cure for ROHHAD, and treatment focuses entirely on managing individual symptoms with a multidisciplinary medical team.
  • About half of children with ROHHAD develop neural crest tumors, adding another layer of medical complexity to their care.
  • Daily life with ROHHAD requires constant vigilance, medical equipment, and round-the-clock supervision, fundamentally changing family dynamics.
  • Research funding comes almost entirely from families and advocacy organizations because the disease is too rare to attract pharmaceutical or government investment.

Understanding the Outlook: What Families Face

When a child receives a diagnosis of ROHHAD syndrome, families are confronted with a deeply serious reality. This condition carries a grave prognosis, and understanding what lies ahead is essential, though heartbreaking. The outlook for children with ROHHAD syndrome is concerning, with medical literature reporting mortality rates between 50 and 60 percent when the condition goes undiagnosed or untreated. This high death rate stems primarily from cardiorespiratory arrest, which means the heart and breathing suddenly stop working together, often without warning.

What makes ROHHAD particularly frightening is its unpredictable nature. Children can experience sudden, life-threatening episodes called cardiorespiratory arrest at any time. These events can happen during sleep, after a mild illness like a common cold, or even following medical procedures that require sedation or anesthesia. The breathing problems that define ROHHAD mean that a child's body may fail to respond normally when oxygen levels drop or carbon dioxide builds up, and this failure can be fatal.

The earlier ROHHAD is identified and management begins, the better a child's chances of survival. Early diagnosis allows healthcare teams to put supportive measures in place, such as breathing support through ventilators and careful monitoring of vital signs. However, even with the best care available, ROHHAD remains a life-limiting condition. To date, medical literature has reported no survival beyond the third decade of life, meaning that most documented cases involve children and young adults, with very few—if any—mature adults living with the syndrome.

Despite the sobering statistics, some children with ROHHAD have lived for years with intensive medical support and vigilant home care. Families become expert caregivers, learning to manage ventilators, monitor oxygen levels, administer medications, and recognize the subtle signs that their child may be in distress. The quality of life varies greatly from child to child, depending on the severity and combination of symptoms they experience.

How ROHHAD Progresses Without Treatment

ROHHAD syndrome does not appear at birth. Babies born with this condition seem completely healthy, meeting all their developmental milestones and growing normally during their first year or two of life. Then, typically between ages 1.5 and 7—most commonly around ages 2 to 4—something shifts dramatically. The first sign is almost always rapid, unexplained weight gain. A child who was at a normal weight can gain 20 to 30 pounds within just six to twelve months, despite no obvious changes in diet or activity. This sudden obesity is often accompanied by increased hunger, a symptom called hyperphagia, where the child feels constantly hungry and seems unable to feel full.

In the months and years following the onset of rapid weight gain, other symptoms begin to emerge in a sequence that varies from child to child. Problems with the hypothalamus—a small but vital part of the brain that controls many automatic body functions—start to surface. The hypothalamus regulates appetite, thirst, body temperature, sleep cycles, growth, and hormone production. When it stops working properly, children may develop issues with their sodium and water balance, leading to dangerously high or low sodium levels in the blood. They may stop growing at a normal rate, resulting in short stature. Some children enter puberty too early, while others experience delayed puberty. Thyroid problems and diabetes can also develop.

As the syndrome progresses, breathing becomes compromised. Children with ROHHAD lose the automatic ability to regulate their breathing, a function most of us never think about because it happens without conscious effort. Their brains fail to signal the body to breathe more deeply or quickly when oxygen levels fall or carbon dioxide rises. This dangerous condition, called hypoventilation, appears first during sleep but can eventually affect breathing even when the child is awake. Left untreated, this leads to respiratory failure, meaning the lungs cannot provide enough oxygen to the body or remove enough carbon dioxide.

Damage to the autonomic nervous system adds another layer of difficulty. This system controls involuntary functions like heart rate, blood pressure, digestion, body temperature, and pain perception. Children may develop a dangerously slow heart rate, experience episodes of abnormally high or low body temperature, sweat excessively or not at all, and have trouble sensing pain normally. Some feel intense pain from minor stimuli, while others may sustain serious injuries without feeling discomfort. Digestive problems such as chronic constipation or diarrhea are common, and some children require surgical intervention to address severe gastrointestinal issues.

Without medical intervention, the natural course of ROHHAD is grim. The combination of uncontrolled breathing problems, unpredictable heart rhythms, and the body's inability to regulate basic functions creates a situation where sudden death becomes increasingly likely. Early and aggressive supportive care is the only way to extend life and improve its quality, but even with intervention, the disease does not go away—it must be managed every single day.

Complications That May Arise

Beyond the hallmark symptoms that define ROHHAD, children with this syndrome can develop a range of serious complications that further complicate their care and affect their well-being. One significant concern is the development of tumors. Approximately 40 to 50 percent of children with ROHHAD will develop neuroblastic tumors, which are growths that arise from nerve tissue. The most common types are ganglioneuromas and ganglioneuroblastomas. These tumors typically appear in the chest or abdomen and are generally considered benign, meaning they are not cancerous and do not spread aggressively. However, they still require monitoring and sometimes surgical removal. Because of this association, some medical professionals refer to the condition as ROHHAD-NET, with "NET" standing for neuroendocrine tumor.

Behavioral and emotional changes represent another troubling complication. Many children with ROHHAD experience mood swings, irritability, aggression, and difficulty controlling their emotions. Some develop a flat affect, meaning they show little emotional expression, while others may exhibit selective mutism, a condition where they stop speaking in certain situations or to certain people. Cognitive challenges and developmental delays can also occur, although intelligence levels vary widely among affected children—some have normal cognitive development, while others struggle significantly.

Eye problems are common and include strabismus, where the eyes do not align properly and point in different directions, and abnormalities in pupil size or response to light. Vision problems can affect a child's ability to read, play, and navigate their environment safely. Seizures can develop in some children, adding yet another layer of medical complexity and requiring additional medications to control.

One of the most dangerous complications is the body's impaired response to illness and medical procedures. A simple cold or respiratory infection that would be minor in a healthy child can trigger respiratory failure in a child with ROHHAD. Similarly, anesthesia used during surgery or sedation for imaging tests can cause severe drops in oxygen levels and dangerously slow heart rates. These reactions can be life-threatening, and every medical procedure must be approached with extreme caution and specialized expertise.

Sodium imbalances represent a particularly serious complication. The hypothalamus normally helps regulate the balance of salt and water in the body, but when it malfunctions, children can develop hypernatremia (too much sodium) or hyponatremia (too little sodium). High sodium levels can cause extreme thirst, confusion, muscle weakness, and even coma. Low sodium levels can lead to nausea, headaches, seizures, and loss of consciousness. Managing these imbalances requires constant vigilance and frequent blood tests.

Daily Life with ROHHAD Syndrome

Living with ROHHAD syndrome transforms every aspect of a child's daily existence and places extraordinary demands on their family. The most visible impact is the need for constant medical equipment and monitoring. Many children with ROHHAD require a tracheostomy, which is a surgical opening in the neck that allows a tube to be inserted directly into the windpipe. This tube connects to a ventilator, a machine that helps the child breathe, especially during sleep. Some children need ventilator support only at night, while others require it around the clock, both asleep and awake. The ventilator must travel everywhere the child goes, and batteries must be charged and ready in case of power outages or travel.

The tracheostomy requires frequent care. Several times each day, a child needs suctioning, a process where a small tube attached to a machine is inserted through the trach opening to remove mucus and secretions. This prevents blockages that could cut off the airway and cause suffocation. Sterile water is squirted down the tube to clean away dried secretions. This procedure is uncomfortable and sometimes frightening for the child, yet it is essential for survival. Families become experts in trach care, learning to perform emergency procedures like changing the tube if it becomes dislodged.

Privacy becomes nearly impossible. Children with ROHHAD cannot be left alone, even for a moment. A parent or trained nurse must be within earshot at all times to respond to alarms from the ventilator or oxygen monitor, to perform suctioning, to administer medications multiple times daily, and to watch for signs of distress. Sleepovers at friends' houses, independent time in their room, or even using the bathroom alone are luxuries these children cannot have. This constant supervision is necessary but can feel isolating and frustrating, especially as children grow older and naturally want more independence.

Physical activity is limited by the need to carry or pull the ventilator and monitor equipment, and by the child's body's inability to regulate breathing during exertion. Running, jumping, swimming, and playing sports become difficult or impossible. The weight gain caused by ROHHAD further restricts movement, creating a cycle where limited activity contributes to continued weight challenges. Children often cannot participate in school gym classes, recess, or after-school activities that other kids enjoy.

School attendance is complicated. Many children with ROHHAD cannot attend regular school because they need specialized medical support that schools cannot provide. They may receive home instruction or attend school part-time with a nurse present. This limits social interaction with peers, making it harder to form friendships and develop social skills. Activities like chorus, drama club, or simply going to a movie with friends require extensive planning and supervision, if they are possible at all.

Eating and weight management become sources of daily struggle. Despite the hunger that ROHHAD causes, children must carefully control their food intake to avoid further weight gain, which worsens breathing problems and mobility. This constant restriction feels unfair and frustrating to children who genuinely feel hungry all the time. Families face the difficult task of saying no to a child who is asking for food because they are genuinely experiencing hunger, not just cravings.

The emotional toll on both the child and family is immense. Children may feel different, isolated, and frustrated by their limitations. Behavioral issues and mood changes, which are part of the syndrome itself, add to the emotional complexity. Parents live with constant fear and vigilance, knowing that their child could experience a life-threatening emergency at any moment. The stress of round-the-clock caregiving, financial pressures from medical expenses and lost work hours, and the emotional weight of caring for a child with a life-threatening condition can strain relationships and mental health. Yet families also demonstrate remarkable resilience, creativity, and love as they adapt to this challenging reality.

Supporting Families Through Clinical Trials and Medical Research

Because ROHHAD syndrome is so rare—affecting fewer than 200 documented individuals worldwide—finding information, connecting with other families, and locating medical professionals who understand the condition can feel overwhelming. Clinical trials and research studies represent a source of hope for families, offering the possibility of new treatments and a deeper understanding of what causes ROHHAD. However, families need practical guidance on how to navigate this landscape and how they can actively participate in advancing knowledge about this devastating condition.

First and foremost, families should understand that because ROHHAD is so rare, most research is still in the early stages of trying to understand what causes the syndrome and how it progresses. There is no cure currently being tested in clinical trials, and treatment remains focused on managing symptoms. However, research studies are underway examining possible autoimmune causes, genetic factors, and potential biomarkers that could help with earlier diagnosis. Some studies have explored the use of immunosuppressive medications, such as high-dose chemotherapy or rituximab, to "reboot" the immune system in the hope of slowing disease progression, though results have been mixed and these remain experimental approaches.

Families can help their child by staying informed about ongoing research. Several organizations dedicated to ROHHAD maintain registries where families can enroll their child and share medical information with researchers. These registries are crucial because they allow scientists to gather data from multiple cases, identify patterns, and develop hypotheses about the disease. Participation usually involves completing questionnaires about symptoms, sharing medical records, and occasionally providing biological samples like blood or saliva. While this does not directly benefit the individual child, it contributes to the collective understanding that may help future children.

When considering participation in a clinical trial or research study, families should ask their medical team several important questions. They should understand the purpose of the study, what procedures will be involved, how much time it will require, whether there are any potential risks or discomforts, and whether the child will receive any direct medical benefit or only contribute to future knowledge. Families should also ask about costs—whether the study covers travel and lodging, since children with ROHHAD often need to travel long distances to reach specialized medical centers.

Relatives and family members can assist in practical ways that make a meaningful difference. They can help research and compile lists of clinical trials by searching databases and contacting advocacy organizations that focus on ROHHAD. They can offer to travel with the family to medical appointments, providing emotional support and an extra set of hands and ears to remember what doctors say. They can help organize medical records, which for a child with ROHHAD quickly become extensive and complicated, making sure everything is copied, organized, and ready when needed for consultations or study enrollment.

Extended family members can also provide respite care, giving primary caregivers a much-needed break. However, this requires specialized training in managing the ventilator, performing suctioning, recognizing signs of distress, and understanding the child's complex medication schedule. Offering to learn these skills and become a trusted backup caregiver is one of the most valuable gifts a family member can give.

Families should connect with patient advocacy organizations specific to ROHHAD. These groups provide a sense of community, connecting families who understand the unique challenges of living with this syndrome. They share practical advice, emotional support, and updates about research developments. Many also organize gatherings where children with ROHHAD and their families can meet, reducing the profound sense of isolation that comes from having an ultra-rare condition. These organizations also advocate for funding for research, raise awareness among medical professionals, and work to improve the quality of life for affected children.

Financially supporting research is another way families and their communities can contribute. Because ROHHAD is classified as an "orphan disease," meaning it affects very few people, pharmaceutical companies and government agencies typically do not allocate research budgets to study it. Research funding comes almost entirely from charitable donations raised by families and advocacy organizations. Fundraising efforts, awareness campaigns, and donations directly support the scientists working to unlock the mysteries of ROHHAD and develop treatments.

Registered drugs used for this disease

There are currently no officially registered drugs specifically approved for the treatment of ROHHAD syndrome. Treatment focuses on managing individual symptoms with medications that address specific complications, such as:

  • Thyroid hormone replacement (e.g., levothyroxine) – Used to treat hypothyroidism caused by hypothalamic dysfunction
  • Desmopressin – Used to manage diabetes insipidus and regulate water balance in the body
  • Medications for heart rate control – Used when autonomic dysfunction causes dangerously slow or fast heart rhythms
  • Medications for gastrointestinal motility – Used to address chronic constipation or diarrhea resulting from autonomic nervous system damage

Some experimental approaches, such as rituximab and cyclophosphamide, have been used in isolated cases based on the theory that ROHHAD may have an autoimmune origin, but these are not officially approved treatments and results have been variable.

Did you know?

  1. Children with ROHHAD are born completely healthy and develop normally until suddenly, between ages 1.5 and 7, their bodies begin to malfunction—making this one of the few conditions where a child can go from thriving to critically ill within months.
  2. A case has been documented involving identical twins where only one developed ROHHAD syndrome, suggesting that factors beyond genetics—possibly environmental triggers or epigenetic changes—play a role in the disease.
  3. Despite being first described in 1965, fewer than 200 cases of ROHHAD have been documented worldwide, making it so rare that most doctors will never encounter a single patient in their entire career.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for ROHHAD syndrome

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

ROHHAD syndrome

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Setmelanotide
  • Sponsor:Universitair Medisch Centrum Utrecht
See all 1 trials →filters applied: condition = ROHHAD syndrome

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).